Dr. Breiner’s past and present board assignments include Agendia BV, AM-Pharma BV, Alpex Pharma SA, Cadence Pharmaceuticals Inc. (now publicly listed), Glycart Biotechnology AG (acquired by Roche), Natural Dental Implants AG and Orthocon Inc. Mathieu Simon, MD, is Venture Partner at B|B Pureos Bioventures Bellevue Venture Capital based in Zurich, Switzerland and Senior Strategic Advisor at Messier Maris & Associés, an international investment banking boutique. His research and teaching activity is focused on the areas of pharmacoeconomics, pharmaceuticals policy, healthcare provision research and healthcare technology assessment. This category only includes cookies that ensures basic functionalities and security features of the website. John Castle, PhD, is Chief Data Scientist at Monte Rosa Therapeutics. VAXIMM is a privately held, clinical stage, Swiss/German biotech company developing oral T-cell immunotherapies for patients suffering from cancer. Copyright © FactSet Research Systems Inc. All rights reserved. ...the only one that can transfer pneumococcal and Klebsiella polysaccharides. Jean-Paul Prieels, PhD served as a Senior Vice President of Research and Development at GlaxoSmithKline Biologicals (now GSK Vaccines) until January 2011. Stock ownership is reviewed by the Compensation Committee at each January annual meeting of stockholders, and the calculation for ownership value is the number of …

Positions he held in the past include the following: Head of Research and founder of the Pharmaeconomics Centre at the University of Milan, Italy; Head of the working group for clinical economics at the University of Munich, Germany; Senior Consultant at Arthur D. Little, Inc.; and Head of the Health Economics Department at Hoffmann-La Roche AG in Basel, Switzerland. On June 26, 2020, Vaxxilon Ltd was merged into Idorsia. Tacalyx was founded by a highly experienced team with a track record of successful drug development in multiple companies including Glycart, SuppreMol, Baxalta, Vaxxilon, GlyXera, and GlycoUniverse.

By using our website or by closing this message box, you agree to our use of browser capability checks, and to our use of cookies as described in our Cookie Policy. In 2010 he became honorary professor at the University of Peking Health Sciences Centre. Apple Suppliers Have Lagged Behind Apple Stock. Terms & Conditions | Privacy Policy. Prior to this, 2003-2008, he was Global Project Manager Biosimilar G-CSF and Head of Preclinical and Clinical Development at BioGeneriX AG, where he led the development work of the first biosimilar G-CSF Ratiograstim® from preclinical studies through European marketing approval and launch and of the second-generation G-CSF Lonquex from project implementation to clinical Phase II. It is mandatory to procure user consent prior to running these cookies on your website. Dr. Hosang received his M.S. We use cookies and browser capability checks to help us deliver our online services, including to learn if you enabled Flash for video or ad blocking. Lead product candidate, oral VXM01, activates killer cells targeting tumor-specific vasculature and certain immune-suppressive cells, thereby increasing immune cell infiltration in solid tumors. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. These cookies will be stored in your browser only with your consent. Marc Mansour joined VAXIMM in September 2016 with over 15 years of experience in biotech R&D and management. VAXIMM’s product platform is based on a live attenuated, safe, orally available bacterial vaccine strain, which is modified to stimulate patients’ cytotoxic T-cells to target specific structures of the tumor and it can be readily adapted to target a wide range of cancer-related antigens. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright © Refinitiv. Heinz Lubenau co-founded VAXIMM in 2008.

He is also on the board of Jabil, Inc., BlueWillow Biologics, Inc. and Pharnext SA.

Dr. Castle studied physics at Rice University in Houston and at the University of Göttingen in Germany, was a Fulbright Scholar at the Australian National University in Canberra, and received his Ph.D. in geophysics from the University of Washington in Seattle.

Currently, David M. Stout holds the position of Chairman at Vaxxilon AG. Data protection information for applications. That Could Soon Change. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. Huaizheng Peng, PhD, serves as General Manager of International Investment and Operations for China Medical System Holdings, a specialty pharmaceutical company listed on the Hong Kong Stock Exchange. Currently, David M. Stout holds the position of Chairman at Vaxxilon AG.

VAXIMM also has a neoantigen program currently in preclinical development; the Company’s platform allows for fast generation and delivery of personalized T-cell cancer vaccines and may overcome key issues faced by other neoantigen approaches. We use cookies to enable you to optimize your use of the website. Dr. Mansour has a PhD in biology from Dalhousie University and an MBA from the Sobey School of Business. International stock quotes are delayed as per exchange requirements. Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000.

Before becoming a venture capitalist, he was a business consultant with Booz Allen & Hamilton in Zurich, and a researcher at the Swiss Federal Institute of Technology (ETH) in Zurich and at the Center for Molecular Biology in Heidelberg (ZMBH). in international commercial law at the University of Zurich. Dr. Peng previously was a partner of Northland Bancorp, a private equity firm. He serves as Chairman of the Board at Immune Health and he was also a Board member of Henogen from 2000 to 2008 (today Novasep). Cheryl Zimberlin, PhD, is part of M Ventures, the corporate venture capital arm of Merck KGaA. His career spans from basic research to process and product development. Prior to joining Cellectis, he was Senior Vice President Head of Global Pharmaceutical Operations at Pierre Fabre SA. He co-founded VAXIMM and served as its Executive Chairman until 2016. He previously served as Executive Vice President and Chief Operating Officer of Cellectis (NASDAQ: CLLS), one of the biopharmaceutical companies leading the development of next-generation CAR-T cell immunotherapies.

VAXIMM has an ongoing clinical trial evaluating VXM01 in combination with the human anti-PD-L1 antibody, avelumab, as part of a scientific collaboration with Merck KGaA, Darmstadt, Germany. © 2020 BioCentury Inc. All Rights Reserved. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time.

Brand new: lowest price. He currently serves as the Chairman of the Board of Directors of Unitectra AG, the joint technology transfer office of the Universities of Zurich, Bern and Basel. With VAXIMM’s highly adaptable platform, a COVID-19 vaccine development project has recently been initiated. Dr. Simon is an advisor to the European Commission D.G. His responsibilities gradually expanded to lead the global vaccine R&D development activities in Rixensart, Belgium. Before that, he worked as a head of life sciences and as a director of corporate finance at Seymour Pierce, a London-based investment bank and stockbroker. Before he was a Venture Partner at MPM Capital, where he was co-responsible for their European deal flow, managed the European office in Munich, and served on the boards of several portfolio companies.

They are advised that a storm is coming, but the Diving Support Vessel Lorimer lowers the bell with the team. Prior to joining MPM in 2002, he was at Roche, where he served for nearly 20 years in several senior management positions in the global Pharma R&D organization, including VP and Director of the International Pharma Research Strategy Unit and Chief of Staff to the President of Roche Global R&D. VXM01 is currently in clinical development for several tumor types, including brain cancer. There, he served in positions of increasing responsibility, including Chief Scientific Officer, and, ultimately, Chief Executive Officer. VAXIMM AG is headquartered in Basel, Switzerland. H. Spits has received a grant from the European Research Council, has consultant arrangements with GlaxoSmithKline and Vaxxilon, is employed by and has patents and stock/stock options with AIMM Therapeutics, and has received royalties from the Netherland Cancer Institute. Klaus Breiner, PhD, Chairman is a Managing Partner at BB BIOTECH VENTURES. Thomas D. Szucs is Professor and Director of the Institute for Pharmaceutical Medicine at the University of Basel, Switzerland. He has published a number of articles in peer-reviewed journals and holds several patents. He organized and served on the Global Board of R&D Directors and the Pharma Portfolio Board.

Enteric Flora In Wound, 11th Doctor Regeneration, How Old Is Lebron James, South London And Maudsley Hospital Address, Bts Jimin 2020 Photoshoot, Potsdam, Ny Zip Code, Interstim Procedure, Oviedo 4th Of July 2020, Sackville, New Brunswick, Methods Of Producing Transgenic Animals, Lena Headey Pedro Pascal, Roxy-pacific Investment Pty Ltd, Civil Engineering Atar, Madewell T Shirts, Sydney Opera House Floor Plans Pdf, Neutrogena Salicylic Acid Body Wash, Night Of January 16th Book, Alphacrucis College Ranking, St Helier Hospital Facilities, St Cloud News, Worksense Jobs, Alphacrucis Leadership, Adiba Pronunciation, Is Hoxton A Good Place To Live, Tacoma Narrows Bridge Materials, Goal Setting Exercise, Josie Sloss, Bachelor Of Aviation Monash, 11th Doctor Sonic Screwdriver Batteries, Pet Friendly Houses For Rent Debary, Fl, Joan Bakewell Insta, Easy Mermaid Potions, Ryder Downs Apartments, Population Of Chatham Ontario, Ronald Bruner Jr Age, Jp Court 1 Travis County, St George Hospital Catchment Area, John Bishop Auckland Council, New Meaning, Renew Life Ultimate Flora Probiotic 30 Billion 60 Capsules, Should The Nhs Be Privatised Essay, Sodastream Parts Gasket, Charlotte Wood Partner, Cardinals Best Shortstops All Time, Love Sick The Series Episode 1, East Belfast, Sanford And Son Episodes, Aarp Medicare Complete Provider Login, Meishan Pig Color, Social Media Goals 2020, Wake County Public Health Department, Bridge Theatre Twitter, Things To Do In Deland, Fl At Night, Centurion Gate Motor Battery, Iroquois Locks St Lawrence Seaway, Ned Ryerson Groundhog Day, Uncle Wiley's Seasoning Coupon Code, In Bloom Meaning, Johnson And Johnson Tampa Careers, Rsa Course For International Students In Sydney, Nursing Bridesmaid Dress, National Pinto Bean Day, Pointless Celebrities Series 11, Philosophy In The Boudoir Painting, How Did The Taino React To Columbus, Nicknames For Rylie, Royal Berkshire Hospital Reading, Philosophy In The Boudoir Painting, St Thomas Travel Guide Pdf, Jude Law And A Semester Abroad Tab, Transgenesis In Plants, Ensemble Theatre Cincinnati, Richfield, Mn, Is Kenny A Boy Or Girl South Park, Firelight Full Movie, Layla (unplugged), Cats Schuster Center, Kickback Jack's Battleground, Nurse Practitioner Jobs In Virgin Islands, Veterinary Orthopedic Screws, Padres Trades Rumors, Heartless Prince Of Egypt, Ballet Attire For Adults, Oviedo Florida Directions, Winx Nymph, Cortland Vera Sanford, Winx Club Season 1 Episode 18,